Review Article
Volume 7 Issue 8 - 2020
Cardiac Biomarkers: A Beneficial Tool in the Diagnosis and Prognostification in Heart Failure- A Focus on Rheumatic Heart Disease
Sujhithra A1, M Chokkalingam2, S Jayanthi3*, Sanjay Andrew Rajaratnam4, D Danis Vijay3, SH Shifa Meharaj3 and R Vidhya3
1Department of Allied Health Sciences, Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education, Kelambakkam,Tamilnadu, India
2Department of Cardiology, Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education, Kelambakkam, Tamilnadu, India
3Department of Microbiology, Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education, Kelambakkam, Tamilnadu, India
4Department of Physiology, Chettinad Hospital and Research Institue(CHRI), Chettinad Academy of Research and Education, Kelambakkam, Tamilnadu, India
*Corresponding Author: S Jayanthi, Department of Microbiology, Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education, Kelambakkam, Tamilnadu, India.
Received: May 20, 2020; Published: July 31, 2020


Globally, 26 million people are affected by Heart failure (HF). Greater number of morbidity and mortality due to cardiovascular diseases are reported as a growing problem worldwide.

A biomarker provides valuable information beyond the available clinical tools, as it reflects the pathophysiological mechanism involved and helps the clinicians in making decisions on patient management. Assessment of cardiac biomarkers has established its role in the routine evaluation and treatment of HF patients.

In the field of cardiology, biomarkers levels have a significant impact on the patient management, diagnosis, in assessing the degree of heart failure and to predict the developing cardiac dysfunction in Acute and Chronic Rheumatic Heart Disease. Despite the array of current biomarkers, technological advancement in molecular biology, cell biology and biochemistry, there remains a knowledge gap.

Ultimately, it is a combination of biomarkers and other parameters like Cardiac Imaging proves them as one of the most beneficial tool in diagnosis and risk stratification in Heart failure. A given biomarker can be a prognostic marker and should be more specific with improved calibration, discrimination and reclassification.

In this review article, the role of cardiac biomarkers like Galectin 3, Gelsolin, Matrix Metalloproteinase-9 (MMP-9), NT pro BNP (N-Terminal pro Brain Natriuretic Peptide), Procollagen Type I C Peptide (PICP), soluble Suppression of Tumorigenicity (sST2), Tenascin C (Tn C) in different cardiac conditions causing Heart Failure like Rheumatic Carditis, Rheumatic Heart diseases, Coronary Artery Diseases, Adults with Congenital Heart Diseases are enumerated in brief.

Keywords: Cardiac biomarkers; Heart Failure; Rheumatic Heart Disease; PICP; Tenascin C; Soluble ST2; Predictive Marker


  1. Kabi S., et al. “Prognostic Significance of First Week NT-ProBNP Levels in Heart Failure”. Alcohol18-75 (2018): 8825.
  2. Immanuel S., et al. “ST2 levels before and after treatment of NYHA III and IV heart failure”. Acta Medica Indonesiana4 (2015).
  3. Nishimura M., et al. “Soluble ST2: A biomarker to monitor heart failure progression and treatment”. Journal of Clinical and Preventive Cardiology4 (2018): 148.
  4. Carter HE., et al. “Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups”. Open Heart1 (2019): e000939.
  5. Tymińska A., et al. “Association of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial Infarction”. Disease Markers (2019).
  6. Karatas Z., et al. “The role of tenascin-C and oxidative stress in rheumatic and congenital heart valve diseases: an observational study”. AKD 4 (2013): 350.
  7. Weir RA., et al. “Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction”. Journal of the American College of Cardiology3 (2010): 243-250.
  8. Banerjee T., et al. “Clinical significance of markers of collagen metabolism in rheumatic mitral valve disease”. Plos One3 (2014).
  9. Kotby AA., et al. “N-Terminal proBNP levels and tissue doppler echocardiography in acute rheumatic carditis”. ISRN Pediatrics (2013).
  10. Argun M., et al. “Plasma gelsolin as a biomarker of acute rheumatic carditis”. Cardiology in the Young7 (2015): 1276-1280.
  11. Karatas Z., et al. “Serum tenascin-C: a novel biomarker for diagnosis and predicting prognosis of rheumatic carditis?”. Journal of Tropical Pediatrics6 (2013): 476-482.
  12. Sarkar S., et al. “Association of rheumatic fever and rheumatic heart disease with plausible early and late-stage disease markers”. The Indian Journal of Medical Research6 (2017): 758.
  13. Lee SD., et al. “Serum insulin-like growth factor-axis and matrix metalloproteinases in patients with rheumatic arthritis or rheumatic heart disease”. Clinica Chimica Acta1-2 (2006): 62-68.
  14. Bakker MK., et al. “Prenatal diagnosis and prevalence of critical congenital heart defects: an international retrospective cohort study”. BMJ Open 7 (2019): e028139.
  15. Cheung YF., et al. “Circulating Transforming Growth Factor-β and Aortic Dilation in Patients with Repaired Congenital Heart Disease”. Scientific Reports1 (2019): 1-9.
  16. Lai CT., et al. “Circulating levels of biomarkers of collagen synthesis and ventricular function and dyssynchrony in adolescents and young adults after repair of tetralogy of Fallot”. American Heart Journal3 (2011): 467-473.
  17. Weinberg EO., et al. “Identification of serum soluble ST2 receptor as a novel heart failure biomarker”. Circulation5 (2003): 721-726.
  18. Bastawesy RB., et al. “Galectin-3 and Severity of The Coronary Artery Disease in Ischemic Patients Guided by Coronary Angiography”. The Egyptian Journal of Hospital Medicine6 (2019): 1371-1376.
  19. Zhang H., et al. “Diagnostic Value of Combined Detection of Galectin-3 and N-Terminal B-Type Natriuretic Peptide in Patients with Acute Heart Failure”. World Journal of Cardiovascular Diseases 3 (2018): 208-216.
  20. Al-Kraity WR and Al-Dujaili AN. “Assessment of Gelsolin Level in women with heart disease after menopause”. Research Journal of Pharmacy and Technology6 (2017): 1657-1660.
  21. Shi SS., et al. “Plasma gelsolin level predicts acute kidney injury after cardiopulmonary bypass in infants and young children”. World Journal of Pediatrics2 (2018): 143-150.
  22. Ram M., et al. “Matrix metalloproteinase-9 and autoimmune diseases”. Journal of Clinical Immunology 4 (2006): 299-307.
  23. Shimokawa KI., et al. “Matrix metalloproteinase (MMP)-2 and MMP-9 activities in human seminal plasma”. Molecular Human Reproduction1 (2002): 32-36.
  24. Matsuki K., et al. “The role of transforming growth factor β1 in the regulation of blood pressure”. Current Hypertension Reviews4 (2014): 223-238.
  25. Vasilez L., et al. “The predictive role of cardiac fibrosis markers in progression of coronary heart disease associated with cardiac arrhythmias and arterial hypertension”. Journal of Biology and Medicine 2 (2018): 69-72.
  26. Harutyunyan MJ., et al. “High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial”. Scandinavian Journal of Clinical and Laboratory Investigation1 (2011): 52-62.
  27. Mukalla Z., et al. “Using N-terminal pro-B-type natriuretic peptide to diagnose cardiac abnormalities in children with dyspneaen with dyspnea”. Paediatrica Indonesiana3 (2017): 124-128.
  28. Bosello S., et al. “Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study”. European Journal of Internal Medicine 60 (2019): 46-53.
  29. Querejeta R., et al. “Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis”. Circulation10 (2004): 1263-1268.
  30. Yang C., et al. “Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy”. Cardiovascular Pathology 43 (2019): 107150.
  31. Villacorta H and Maisel AS. “Soluble ST2 testing: a promising biomarker in the management of heart failure”. Arquivos Brasileiros De Cardiologia2 (2016): 145-152.
  32. Lancellotti P., et al. “Elevated plasma soluble ST2 is associated with heart failure symptoms and outcome in aortic stenosis”. PLoS One9 (2015).
  33. Shi LJ., et al. “Elevated levels of soluble ST2 were associated with rheumatoid arthritis disease activity and ameliorated inflammation in synovial fibroblasts”. Chinese Medical Journal3 (2018): 316.
  34. Geenen LW., et al. “Prognostic value of soluble ST2 in adults with congenital heart disease”. Heart 13 (2019): 999-1006.
  35. Bahuleyan CG., et al. “Prognostic value of soluble ST2 biomarker in heart failure patients with reduced ejection fraction–a multicenter study”. Indian Heart Journal 70 (2018): S79-S84.
  36. Januska R., et al. “Soluble ST2-A Potential Biomarker of Rheumatic Heart Disease”. Clinical Medical Reviews and Case Reports 6 (2019): 255.
  37. Van Vark LC., et al. “Prognostic value of serial ST2 measurements in patients with acute heart failure”. Journal of the American College of Cardiology19 (2017): 2378-2388.
  38. Satta J., et al. “Progression of human aortic valve stenosis is associated with tenascin-C expression”. Journal of the American College of Cardiology1 (2002): 96-101.
  39. Celik A., et al. “An investigation of tenascin-C levels in rheumatic mitral stenosis and their response to percutaneous mitral balloon valvuloplasty”. Medical Principles and Practice1 (2013): 29-34.
  40. Guo T., et al. “The Role of Serum Tenascin-C in Predicting In-Hospital Death in Acute Aortic Dissection”. International Heart Journal 18 (2019): 462.
  41. Yokouchi Y., et al. “Expression of tenascin C in cardiovascular lesions of Kawasaki disease”. Cardiovascular Pathology 38 (2019): 25-30.
  42. Gao W., et al. “Tenascin C: A Potential Biomarker for Predicting the Severity of Coronary Atherosclerosis”. Journal of Atherosclerosis and Thrombosis (2018): 42887.
Citation: S Jayanthi., et al. “Cardiac Biomarkers: A Beneficial Tool in the Diagnosis and Prognostification in Heart Failure- A Social Focus on Rheumatic Heart Disease”. EC Cardiology 7.8 (2020): 36-48.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 14, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.